
“Exosome skin booster” is one of the most searched treatment names of the past two years. Dr Sin Yong at IN Eternity Clinic on Orchard Road explains what these products are, their regulatory status and where they fit.
WhatsApp to Enquire →Key facts ↓An “exosome skin booster” is usually a topical product containing extracellular vesicles, applied to the skin straight after a procedure such as microneedling or fractional laser, while tiny channels are still open. Exosome products are not registered by HSA for injection, and evidence is still early. At IN Eternity Clinic they are used topically only, as aftercare support.
Almost every cell releases tiny membrane-bound packages into its surroundings. These extracellular vesicles carry proteins, fats and fragments of RNA, and other cells take them up as signals. Exosomes are one subtype, typically tens to around a hundred and fifty nanometres across, formed inside the cell before release. In wound healing research, vesicles released by stem cells and skin cells appear to influence inflammation, blood vessel growth and collagen production, which is why they attracted interest in skin medicine.
The science is genuine, but the vocabulary is loose. Isolating pure exosomes is technically hard, and the International Society for Extracellular Vesicles recommends the broader term “extracellular vesicles” unless a preparation has been characterised in detail. Many products labelled “exosome” are better described as vesicle-containing solutions or cell-culture extracts. That matters for patients, because two products with the same label may contain very different things.

Products sold to aesthetic clinics vary in source and in how they are made. Some are derived from human cell cultures, most often adipose-derived or other stem cells, with the vesicles separated from the culture fluid and freeze-dried. Others are plant-derived vesicle preparations, and some use other biological sources. Many are mixed with peptides, growth-factor-like ingredients or hyaluronic acid.
Labels often state a particle count, but counts measured by different methods are not directly comparable, and a high number does not show what the particles carry or whether they are active. Storage, freeze-drying and reconstitution all affect the final product. This is one reason a review of exosomes in cutaneous aesthetics concluded that, although early findings are promising, standardisation and larger controlled studies are still needed.
“If I cannot tell you what is in the vial and what it is registered for, it does not go under your skin. Exosomes stay on the surface.”
No exosome product is registered by Singapore’s Health Sciences Authority (HSA) for injection into the skin. Injecting biological material of uncertain source and content raises questions about sterility, contamination and immune reactions that topical use largely avoids. Elsewhere, the United States Food and Drug Administration has not approved any exosome product for aesthetic use and has warned consumers about unapproved exosome products marketed for injection. In several Asian markets, exosome skin products are sold as cosmetics intended for application to the skin.
For that reason, IN Eternity Clinic does not inject exosome preparations; the reasoning is set out on treatments we choose not to offer. If a clinic offers to inject an exosome product as a skin booster, it is reasonable to ask what the product is, where it is made, what it is registered for and what happens if you react to it. HSA registration explained describes how to check.

On intact skin, vesicles have limited ability to cross the outer barrier. Their use in aesthetics is therefore mostly immediately after a procedure that opens temporary channels in the skin, such as microneedling, RF microneedling or fractional laser. The product is spread over the treated area in the minutes after the procedure, sometimes followed by a soothing mask, and occasionally provided for use over the next day or two.
The aim is to support the recovery phase: calming redness, helping the barrier rebuild and supporting the repair response the procedure has started. A randomised split-face study combining an adipose stem cell-derived exosome solution with fractional CO2 laser for acne scars reported better scar improvement and less post-treatment redness on the exosome side; a similar split-face study with microneedling for ageing skin reported improvements in wrinkles and elasticity. Both were small, and both used one specific product, so the findings do not automatically apply to other brands.
What is reasonably supported: vesicles from certain cell sources influence skin cells in the laboratory, and a handful of small human studies report faster settling and some added improvement when a characterised exosome product is applied after microneedling or laser. What is not yet established: the right dose, how often to apply it, how one product compares with another, whether results last, and long-term safety across the wide range of products sold.
That places exosome boosters as an adjunct, not a stand-alone treatment. Applied to unbroken skin as a serum, they are unlikely to do more than a well-formulated moisturiser. Used after a procedure, they may help recovery. They are not a substitute for the procedure itself, for sun protection, or for an injectable booster where the skin genuinely needs dermal support. The older exosome treatment guide covers their use in scalp care as well.
It is also worth knowing who funds the research. Much of the early clinical work has been carried out with a single manufacturer’s product, often in small groups followed for weeks rather than years. That does not make the findings wrong, but it does mean they need confirming in larger, independent studies before firm conclusions are drawn about exosomes as a class.
At IN Eternity Clinic, exosome products are used topically after selected procedures, such as fractional resurfacing, RF microneedling or scalp treatments, where supporting recovery is useful. They are not injected, and they are not sold as a stand-alone booster session. Products are obtained through authorised suppliers, as described on product sourcing.
If the goal is a skin booster in the usual sense, improving hydration, texture and resilience in the dermis, registered injectables are used instead. Polynucleotides such as Rejuran suit thin or sensitised skin, hyaluronic acid boosters suit dehydration, and PDLLA boosters such as Juvelook suit texture. For people who prefer to avoid injections, the needle-free Deep Synergy Booster uses ultrasound delivery. Dr Sin Yong will tell you at assessment which option suits your skin and why.
Because products vary so much, a few questions sort careful use from marketing. What is the product, who makes it and what is its source: human cell culture, plant or another origin? Is it registered or notified for the way it is being used, and is it applied to the skin or injected? What procedure is it being combined with, and why? What evidence supports that specific product, rather than exosomes in general?
It is also fair to ask what happens if you react to it, and whether the procedure alone would achieve most of the benefit. Topical exosome products after fractional laser or microneedling add a modest step to a plan; they should not be the reason for choosing a treatment. If the answers are vague, or the product is offered as an injection, it is reasonable to decline.
Exosomes are also promoted for hair loss and for healing after procedures elsewhere on the body. The same principles apply: know the source, know the route, and judge the evidence for that use rather than for the field as a whole. For scalp care, the hair loss treatment page explains how topical products sit alongside medical treatment and light-based therapy.
It is usually a topical product containing extracellular vesicles, tiny signalling packages released by cells, applied straight after microneedling or fractional laser while the skin is temporarily open. The aim is to support recovery and the repair response the procedure starts. Despite the name, it is not an injectable booster in the way Rejuran or Profhilo is.
No exosome product is registered by HSA for injection into the skin, and IN Eternity Clinic does not inject exosome preparations. If someone offers to inject an exosome product as a booster, ask what the product is, where it is made and what it is registered for; the HSA registration page on our site explains how to check a product.
Small randomised split-face studies have reported added improvement and calmer recovery when a specific exosome solution was applied after fractional CO2 laser or microneedling. The studies are small and product-specific, and dosing is not standardised. Exosomes are better seen as an adjunct to a procedure than as a treatment on their own.
Applied topically to skin after a procedure, reported side effects in studies have been mild, such as temporary redness or irritation. Long-term data across the many products on the market is limited, and content varies between brands. Products used at IN Eternity Clinic come from authorised suppliers, and your history and allergies are reviewed first.
They are different. PRP is prepared from your own blood on the day; exosome products are manufactured from other sources and processed in a laboratory. Comparisons between them are limited, so neither can be called better. Dr Sin Yong chooses based on your concern, the procedure planned and the evidence for that use.
At IN Eternity Clinic, exosome products are used as part of a procedure such as fractional laser or RF microneedling rather than sold as a separate session, so cost depends on the procedure, the area and the number of sessions. A written, itemised quote is given after assessment. The consultation fee is waived with any medical treatment.
IN Eternity Clinic, 9 Scotts Road, #12-01 Pacific Plaza, Singapore 228210. By appointment with Medical Director Dr Sin Yong. Monday to Saturday, 11am to 8pm. WhatsApp or call +65 8815 3008.
These sources describe mechanisms and general evidence. They are not a promise of any individual result; suitability is decided at an in-person assessment.